Global liquid biopsy market expected to generate approximately USD 12,062 million by 2025, at a CAGR of slightly above 38.3% between 2019 and 2025. A biopsy is a tissue or cell sample taken from any part of the human body, which is sent to the lab for examining various disease types.
The report covers a forecast and an analysis of the liquid biopsy market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the liquid biopsy market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the liquid biopsy market on a global level.
In order to give the users of this report a comprehensive view of the liquid biopsy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product, and regional expansion of major participants involved in the market.
The study provides a decisive view of the liquid biopsy market based on target analyte, analytical, application, sample, cancer type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some major players in the global liquid biopsy market include Biocept, Cynvenio, NeoGenomics Laboratories, Qiagen, Trovagene, RainDance Technologies, Guardant Health, Exosome Diagnostics, SAGA Diagnostics AB, Circulogene Theranostics, Inivata, Agena Bioscience, Admeria Health Personal Genome Diagnostics, and Adaptive Biotechnologies.
This report segments the global liquid biopsy market into:
Global Liquid Biopsy Market: Target Analyte Analysis
Global Liquid Biopsy Market: Analytical Analysis
Global Liquid Biopsy Market: Application Analysis
Global Liquid Biopsy Market: Sample Analysis
Global Liquid Biopsy Market: Cancer Type Analysis
Global Liquid Biopsy Market: End-User Analysis
Global Liquid Biopsy Market: Regional Analysis
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed